PharmaCann Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • IPO Registration

  • Employees
  • 3,100

Employees

  • Latest Deal Type
  • IPO
  • (Announced)

  • Latest Deal Amount
  • $1B

  • Investors
  • 12

PharmaCann General Information

Description

Operator of a vertically integrated cannabis company intended to provide safe, reliable, and quality cannabis products to improve people's lives. The company specializes in cultivating, processing, and dispensing medicinal cannabis products and developing new forms and formulations of cannabinoid-based treatments for adult and pediatric patients, providing users with effective, affordable, and trusted cannabis products and services that help them live better lives.

Contact Information

Ownership Status
In IPO Registration
Financing Status
Venture Capital-Backed
Corporate Office
  • 190 South LaSalle Street
  • Suite 2950
  • Chicago, IL 60303
  • United States
+1 (312)
Primary Industry
Other Consumer Non-Durables
Other Industries
Other Pharmaceuticals and Biotechnology
Vertical(s)
Cannabis, LOHAS & Wellness
Corporate Office
  • 190 South LaSalle Street
  • Suite 2950
  • Chicago, IL 60303
  • United States
+1 (312)

PharmaCann Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

PharmaCann Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
18. IPO 16-Aug-2024 $1B Announced Generating Revenue
17. Later Stage VC 09-Apr-2024 Completed Generating Revenue
16. Later Stage VC 05-Apr-2023 Completed Generating Revenue
15. Debt - General 30-Jun-2022 Completed Generating Revenue
14. Debt - General 20-Jan-2022 Completed Generating Revenue
13. IPO 24-Aug-2021 Cancelled Generating Revenue
12. Later Stage VC 25-Jun-2021 Completed Generating Revenue
11. Later Stage VC 18-Mar-2021 Completed Generating Revenue
10. Later Stage VC 01-Sep-2020 $35.9M $180M Completed Generating Revenue
9. Later Stage VC 01-Feb-2020 $19.6M $144M Completed Generating Revenue
To view PharmaCann’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

PharmaCann Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a vertically integrated cannabis company intended to provide safe, reliable, and quality cannabis products t
Other Consumer Non-Durables
Chicago, IL
3,100 As of 2022

Mississauga, Canada
 

Chicago, IL
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

PharmaCann Competitors (5)

One of PharmaCann’s 5 competitors is TerrAscend, a Formerly VC-backed company based in Mississauga, Canada.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
TerrAscend Formerly VC-backed Mississauga, Canada
Grassroots Cannabis Formerly VC-backed Chicago, IL
REV (Pharmaceuticals) Venture Capital-Backed Fitchburg, MA
Lotus Cannabis Company Corporation Vancouver, Canada
Auxly Cannabis Group Corporation Toronto, Canada
You’re viewing 5 of 5 competitors. Get the full list »

PharmaCann Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

PharmaCann Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds
Endowment Wealth Management Asset Manager Minority
Key Investment Partners Venture Capital Minority
Leggett Ventures PE/Buyout
Cronos Group (Pharmaceuticals) Corporation Minority
Artemis Growth Partners Impact Investing Minority
You’re viewing 5 of 12 investors. Get the full list »

PharmaCann Investments & Acquisitions (4)

PharmaCann’s most recent deal was a Merger/Acquisition with The Clinic (Clinics/Outpatient Services). The deal was made on 09-Sep-2022.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
The Clinic (Clinics/Outpatient Services) 09-Sep-2022 Merger/Acquisition Clinics/Outpatient Services
LivWell Enlightened Health 28-Feb-2022 Merger/Acquisition Other Pharmaceuticals and Biotechnology
Elevate Takoma Dispensary 04-May-2021 Corporate Asset Purchase Buildings and Property
Grassroots' Principals Dispensary 04-May-2021 Corporate Asset Purchase Buildings and Property
To view PharmaCann’s complete investments and acquisitions history, request access »

Affiliates

Subsidiaries (2)

Name Industry Location Year Founded
LivWell Enlightened Health Thornton, CO 2009
The Clinic (Clinics/Outpatient Services) Denver, CO 2009

PharmaCann FAQs

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »